Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases is a research paper published in FEBS Journal (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Eye Institute
Grant: EY026177
National Eye Institute
Grant: EY030366
NEI NIH HHS
Grant: R01 EY034238
NEI NIH HHS
Grant: R01 EY026177
NEI NIH HHS
Grant: R01 EY030366
FWCI
2.36
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords